Reuters logo
BRIEF-Sanofi sees Soliqua costing about same as a GLP-1 drug in U.S.
2016年11月22日 / 下午12点47分 / 1 年前

BRIEF-Sanofi sees Soliqua costing about same as a GLP-1 drug in U.S.

Nov 22 (Reuters) - Sanofi :

* Says expects daily wholesale acquisition cost of new diabetes drug Soliqua will be similar to daily price of a GLP-1 in U.S.

* Comment made by spokesman in response to Reuters inquiry Further company coverage: (Reporting by UK bureau)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below